What the prevalence and incidence rates of Alzheimer disease 2017 by state ? i need it as Excel.
Cause amd Characteristics of
Alzheimer’s
disease
Most common cause of dementia; accounts for an estimated 60 percent
to 80 percent of cases. Autopsy studies show
that about half of these cases involve solely Alzheimer’s
pathology; many of the remaining cases have evidence of
additional pathologic changes related to other dementias. This is
called mixed pathology, and if recognized during life is
called mixed dementia.
Difficulty remembering recent conversations, names or events is
often an early clinical symptom; apathy and depression
are also often early symptoms. Later symptoms include impaired
communication, disorientation, confusion, poor judgment,
behavioral changes and, ultimately, difficulty speaking, swallowing
and walking.
Revised guidelines for diagnosing Alzheimer’s were proposed and
published in 2011 (see page 15). They recommend that
Alzheimer’s be considered a slowly progressive brain disease that
begins well before clinical symptoms emerge.
The hallmark pathologies of Alzheimer’s are the progressive
accumulation of the protein fragment beta-amyloid (plaques)
outside neurons in the brain and twisted strands of the protein tau
(tangles) inside neurons. These changes are eventually
accompanied by the damage and death of neurons.
Diagnosis of Alzheimer’s Dementia
There is no single test for Alzheimer’s dementia.
Instead, physicians (often with the help of specialists
such as neurologists and geriatricians) use a variety of
approaches and tools to help make a diagnosis. They
include the following:
• Obtaining a medical and family history from the
individual, including psychiatric history and history
of cognitive and behavioral changes.
• Asking a family member to provide input about
changes in thinking skills and behavior.
• Conducting cognitive tests and physical and
neurologic examinations.
• Having the individual undergo blood tests and brain
imaging to rule out other potential causes of dementia
symptoms, such as a tumor or certain vitamin deficiencies.
• In some circumstances, using brain imaging to find
out if the individual has high levels of beta-amyloid, a
hallmark of Alzheimer's; normal levels would suggest
Alzheimer's is not the cause of dementia.
Diagnosing Alzheimer’s dementia requires a careful and
comprehensive medical evaluation. Although physicians
can almost always determine if a person has dementia, it
may be difficult to identify the exact cause. Several days
or weeks may be needed for an individual to complete the
required tests and examinations and for the physician to
interpret the results and make a diagnosis.
Brain Changes Associated with Alzheimer’s Disease
A healthy adult brain has about 100 billion neurons,
each with long, branching extensions. These extensions
enable individual neurons to form connections with
other neurons. At such connections, called synapses,
information flows in tiny bursts of chemicals that are
released by one neuron and detected by a receiving
neuron. The brain contains about 100 trillion synapses.
They allow signals to travel rapidly through the brain’s
neuronal circuits, creating the cellular basis of memories,
thoughts, sensations, emotions, movements and skills.
The accumulation of the protein fragment beta-amyloid
(called beta-amyloid plaques) outside neurons and the
accumulation of an abnormal form of the protein tau
(called tau tangles) inside neurons are two of several
brain changes associated with Alzheimer’s. Beta-amyloid
plaques are believed to contribute to cell death by
interfering with neuron-to-neuron communication
at synapses, while tau tangles block the transport of
nutrients and other essential molecules inside neurons.
As the amount of beta-amyloid increases, a tipping point
is reached at which abnormal tau spreads throughout
the brain.11
Other brain changes include inflammation and atrophy.
The presence of toxic beta-amyloid and tau proteins
activates immune system cells in the brain called
microglia. Microglia try to clear the toxic proteins as well
as widespread debris from dead and dying cells. Chronic
inflammation is believed to set in when the microglia can’t
keep up with all that needs to be cleared. Atrophy, or
shrinkage, of the brain occurs because of cell loss. Normal
brain function is further compromised by the decreased
ability of the brain to metabolize glucose, its main fuel.
Research suggests that the brain changes associated with
Alzheimer’s may begin 20 or more years before symptoms
appear.12-15 When the initial changes occur, the brain
compensates for them, enabling individuals to continue
to function normally. As neuronal damage increases, the
brain can no longer compensate for the changes and
individuals show subtle cognitive decline. Later, neuronal
damage is so significant that individuals show obvious
cognitive decline, including symptoms such as memory
loss or confusion as to time or place. Later still, basic
bodily functions such as swallowing are impaired.
While research settings have the tools and expertise to
identify some of the early brain changes of Alzheimer’s,
additional research is needed to fine-tune the tools’
accuracy before they become available for clinical use.
In addition, treatments to prevent, slow or stop these
changes are not yet available, although many are being done many clinical trails.
What the prevalence and incidence rates of Alzheimer disease 2017 by state ? i need it...
If prevalence of a disease is proportional to the incidence times the duration of the disease, what will happen to prevalence when the duration of the disease increases? Group of answer choices incidence will be higher than prevalence prevalence will be higher than incidence prevalence and incidence will be equal incidence will first decrease then increase
Prevalence and incidence-what does each one mean? How might they vary? What could influence the incidence and prevalence rates? Which one measures the burden of disease and which one is used to investigate causes/risk factors of disease?
Incidence and prevalence rates can also be used to compare the rates of disease across different settings (places), people, or time. We therefore need measures of comparison. The ratio of two measures of disease frequency is called the relative risk. The difference between two measures of disease frequency is called the risk difference, or rate difference. In some cases, it involves a measure in an exposed group (or groups) and a measure in an unexposed or comparison group. In other...
epidemiological overview: what is the incidence, prevalence, morbidity rate of cardiovascular disease in Central Florida?
Disease occurrence can be measured as prevalence or incidence. Which measure is better suited for the evaluation of preventive programs? A) cumulative incidence B) prevalence C) A and C D) incidence rate E) A and B
9. The following table describes trends in prevalence and incidence of chronic invariably fatal disease from 2093 to 2013, Which of the following describes the above trends? a. The case fatality rate from Disease Z is increasing b. The duration of Disease Z is becoming shorter c. The duration of Disease Z is becoming longer d. Both A and B may be correct e. None of the above Prevalence and Incidence of Rates of Disease Z Among U.S. Adults 25-44...
Indicate whether the following is an incidence proportion, incidence rate, prevalence. (1/2 point each) Incidence proportion/ Cumulative incidence Incidence rate / incidence density Prevalence 7 number of women in town of Framingham who reported having heart disease in recent health survey estimated number of women residents of Framingham during same period L number of women in Framingham Study who have died through last year from heart disease number of person-years contributed through last year by women initially enrolled in Framingham...
Which factors can decrease an observed prevalence of a disease? [Choose the ONE best answer): A. Decrease in incidence B. Better reporting of diagnoses C. Improved cure rates of disease D. A decrease in incidence and improved cure rates of the disease
Note; Parkinson's Disease 3. What is the 1) incidence and 2) prevalence of PD in America? (2 pts) 4. Briefly describe what happens in the brain of people with PD (2 pts) 5. In your own words, how would you describe the PD severity of someone who is stage 3 on the Hoehn and Yahr scale? (1 pt)
Most everyone agrees that when studying the incidence and prevalence of disease in populations, the research should be evidence-based. That is, to the extent possible, researchers should draw their conclusions after collecting and analyzing valid and reliable data. This is a good general principle. But sometimes healthcare professionals find they need to take action when solid data does not exist. Explain why this is so. Provide an example to support your point.